Rob Aspbury
Directeur des opérations chez Certara UK Ltd.
Profil
Rob Aspbury has worked as a Director at XenologiQ Ltd since 2020 and as the Chief Operating Officer at Certara UK Ltd since 2019.
Postes actifs de Rob Aspbury
| Sociétés | Poste | Début |
|---|---|---|
Certara UK Ltd.
 Certara UK Ltd. BiotechnologyHealth Technology Certara UK Ltd. provides platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human populations and virtual laboratory animals. The company was founded by Geoffrey Thomas Tucker, Amin Rostami-Hodjegan, and John Evans on May 15, 2001 and is headquartered in London, the United Kingdom. | Directeur des opérations | 17/04/2019 |
XenologiQ Ltd.
 XenologiQ Ltd. Miscellaneous Commercial ServicesCommercial Services XenologiQ Ltd. provides consultancy services for the drug industry. It offers services in the areas of pharmacokinetic pharmacodynamics modelling, systems pharmacology and training. The firm projects include conference presentations; dose prediction for novel biological drugs and nerve growth factor pathways systems pharmacology. The company was founded in 2011 and is headquartered in London, United Kingdom. | Directeur/Membre du Conseil | 01/01/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Certara UK Ltd.
Certara UK Ltd. BiotechnologyHealth Technology Certara UK Ltd. provides platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human populations and virtual laboratory animals. The company was founded by Geoffrey Thomas Tucker, Amin Rostami-Hodjegan, and John Evans on May 15, 2001 and is headquartered in London, the United Kingdom. | Health Technology |
XenologiQ Ltd.
XenologiQ Ltd. Miscellaneous Commercial ServicesCommercial Services XenologiQ Ltd. provides consultancy services for the drug industry. It offers services in the areas of pharmacokinetic pharmacodynamics modelling, systems pharmacology and training. The firm projects include conference presentations; dose prediction for novel biological drugs and nerve growth factor pathways systems pharmacology. The company was founded in 2011 and is headquartered in London, United Kingdom. | Commercial Services |